L-Valine, 3-methyl-N-(trifluoroacetyl)- (9CI) CAS:666832-71-9

In organic chemistry, L-Valine, 3-methyl-N-(trifluoroacetyl)- (9CI) serves as a versatile building block for the assembly of peptide chains with specific valine-containing motifs. Its trifluoroacetyl protection group facilitates selective peptide bond formation and modification, allowing for the tailored synthesis of peptide analogs, peptide conjugates, and peptidomimetics. Researchers utilize this compound to explore the structure-activity relationships of peptides, design peptide-based therapeutics, and develop novel peptide sequences with enhanced biological properties. The compound finds applications in peptide synthesis and drug discovery, where it plays a pivotal role in creating peptide molecules with diverse pharmacological activities and target interactions. L-Valine, 3-methyl-N-(trifluoroacetyl)- (9CI) enables the incorporation of valine residues into peptide structures for enhancing their stability, bioavailability, and binding affinity to biological receptors. Its use in peptide modification and functionalization contributes to the development of peptide drugs, enzyme inhibitors, and diagnostic agents with potential applications in biotechnology, pharmaceuticals, and biomedical research. Within the pharmaceutical industry, L-Valine, 3-methyl-N-(trifluoroacetyl)- (9CI) is utilized for the synthesis of valine-containing peptides, peptidic prodrugs, and peptide-based nanoparticles for drug delivery. Its role in peptide chemistry and peptide engineering allows for the design of novel peptide scaffolds with improved therapeutic properties and reduced immunogenicity. By leveraging the unique characteristics of this compound, scientists can explore new avenues in peptide-based drug development, personalized medicine, and targeted therapy for various diseases, including cancer, infectious diseases, and metabolic disorders.